Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom
Douglas C.A. Taylor+4 more
openalex +1 more source
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: An open-label pilot study [PDF]
J. Taylor Hays+4 more
openalex +1 more source
Response to Letter Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial” [PDF]
Nancy A. Rigotti+5 more
openalex +1 more source
Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats [PDF]
Jade J. Bito‐Onon+4 more
openalex +1 more source
Use of low-dose varenicline in patients who do not tolerate standard-dose varenicline: A longitudinal case series. [PDF]
Swanson M, Masclans LC, Davis JM.
europepmc +1 more source
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials [PDF]
David P. King+8 more
openalex +1 more source
Smoking Cessation Strategies After Acute Coronary Syndrome. [PDF]
Nazir A+4 more
europepmc +1 more source
A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates [PDF]
S. I. Rennard+7 more
openalex +1 more source
Varenicline for tobacco dependence: panacea or plight? [PDF]
Jill M. Williams+5 more
openalex +1 more source